| Product NDC: | 51079-121 |
| Proprietary Name: | Lansoprazole |
| Non Proprietary Name: | lansoprazole |
| Active Ingredient(s): | 30 mg/1 & nbsp; lansoprazole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE PELLETS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51079-121 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090763 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120824 |
| Package NDC: | 51079-121-08 |
| Package Description: | 80 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-121-08) > 1 CAPSULE, DELAYED RELEASE PELLETS in 1 BLISTER PACK (51079-121-01) |
| NDC Code | 51079-121-08 |
| Proprietary Name | Lansoprazole |
| Package Description | 80 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-121-08) > 1 CAPSULE, DELAYED RELEASE PELLETS in 1 BLISTER PACK (51079-121-01) |
| Product NDC | 51079-121 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lansoprazole |
| Dosage Form Name | CAPSULE, DELAYED RELEASE PELLETS |
| Route Name | ORAL |
| Start Marketing Date | 20120824 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | LANSOPRAZOLE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |